Diagnostics

A new walk-in lab with pediatric care opens in The Marketplace at Steamtown, marking a strategic move in retail health and enhancing local convenience.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

A groundbreaking partnership in Italy is creating an AI-powered biobank to transform cancer diagnosis, promising faster, more accurate results for patients.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

Hemex Health's portable Gazelle test gets FDA Breakthrough status, paving an accelerated path for a device already changing lives in over 40 countries.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

The deli giant reopens its Jarratt, VA facility with new tech and top experts after a fatal Listeria crisis. It's a high-stakes bet on rebuilding trust.

The Rainwater Foundation awards $600,000 to pioneering scientists, accelerating breakthroughs in treating devastating neurodegenerative tauopathies.

A new partnership aims to overcome the hurdles of at-home testing by combining instrument-free PCR with advanced enzymes for rapid, reliable results.

The nation's top infectious disease lab partners with SYNERGEN Health, using AI to combat claim denials and future-proof its national expansion.

VectorY Therapeutics adds seasoned biotech architect Kevin Pojasek to its board, signaling a strategic push to accelerate its novel therapies for ALS and Alzheimer's.

A new hybrid exhibition model connects global buyers with Asian smart medical innovators for an unprecedented four-month period, signaling a major shift.

After a record year in the U.S., Mauna Kea Technologies unveils a new international strategy and leadership model to scale its diagnostic platforms globally.

CoSara Diagnostics' ISO 13485 certification paves the way for regulatory approval of a new PCR platform, leveraging India's 'Make in India' initiative.

With $130M in total funding, AI-scent pioneer Osmo is expanding its team to disrupt the fragrance market and unlock new frontiers in health and safety.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.